What is the clinical significance of an autoantibody of uncertain relevance detected on a Myomarker 3 Plus panel (negative for myositis‑specific and myositis‑associated antibodies by RIPA gel radiography) in a patient with established psoriatic arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Autoantibody of Unknown Significance in Psoriatic Arthritis Patient

The detection of an autoantibody of uncertain relevance on your Myomarker 3 Plus panel is most likely a false-positive result with no clinical significance, particularly since you have no clinical signs of myositis (muscle weakness, elevated muscle enzymes) and the myositis-specific antibodies were appropriately negative.

Understanding Your Results

Your test showed:

  • Negative for myositis-specific and myositis-associated antibodies by RIPA gel radiography (the gold standard method)
  • An unidentified autoantibody detected of unknown significance

Clinical Significance

This finding is likely clinically irrelevant for several key reasons:

  • Commercial immunoassays for myositis antibodies have a false-positive rate of 12-14% in tested populations 1, 2
  • Up to 60% of weak-positive or borderline myositis antibody results are not associated with any specific rheumatic disease 1
  • The positive predictive value of myositis antibody testing is substantially reduced when used in populations with low pretest probability (i.e., patients without muscle weakness or elevated muscle enzymes) 3
  • In healthy controls, low-level autoantibody reactivity can be detected in a significant proportion of individuals without disease 4

What This Means for Your Psoriatic Arthritis

Your psoriatic arthritis diagnosis remains unchanged. Psoriatic arthritis patients are typically seronegative for most autoantibodies 5, 6. The presence of this uncertain autoantibody does not:

  • Indicate overlap with inflammatory myositis
  • Change your treatment approach
  • Suggest a different diagnosis
  • Require additional immunosuppression

When to Be Concerned (Red Flags)

You should contact your rheumatologist immediately if you develop:

  • Proximal muscle weakness (difficulty standing from a chair, lifting arms overhead, climbing stairs)
  • Muscle pain with weakness (not just pain alone)
  • Elevated muscle enzymes (CK, aldolase, AST, ALT)
  • Severe fatigue limiting daily activities
  • Difficulty swallowing or respiratory symptoms

Important distinction: Muscle pain alone without weakness is common in many conditions and does not indicate myositis 5.

Recommended Action

No immediate action is required based on this isolated finding. However:

  • Continue routine monitoring of your psoriatic arthritis as planned
  • Do not pursue additional myositis-specific testing unless clinical symptoms develop
  • If muscle symptoms arise, your physician should check CK levels and inflammatory markers (ESR, CRP) before considering repeat antibody testing 5
  • Be aware that RIPA gel radiography (which was negative in your case) is more reliable than other immunoassay methods for detecting clinically significant myositis antibodies 2, 3

Technical Context

The limitations of myositis antibody testing are well-recognized. Studies show that line blot and dot blot assays have significant limitations, particularly for detecting certain antibodies and generating false-positive results 2, 7. The fact that your RIPA test (the reference standard) was negative while an unspecified antibody was detected suggests this is likely a technical artifact rather than a clinically meaningful finding.

Bottom line: This uncertain autoantibody finding should not alter your clinical management or cause concern in the absence of muscle-related symptoms. Your established psoriatic arthritis diagnosis and treatment plan remain appropriate.

References

3
Research

Autoantibody testing in myositis: an update.

Current opinion in rheumatology, 2024

Related Questions

What is the recommended intravenous fluid regimen using D5 ½ NS (5% dextrose in half normal saline) for a patient with viral myositis?
Can you interpret the ankle imaging findings that show a normal mortise joint and talar dome with no fracture, bony lesion, arthritic change, or effusion, but a plantar enthesophyte?
What are myositis antibodies?
Which blood tests should be ordered to screen for dermatomyositis?
What is the recommended workup for suspected myositis?
Is isotretinoin associated with an increased risk of deep vein thrombosis (DVT) and should it be avoided in patients with a prior DVT or other thrombotic risk factors?
In a pre‑operative clearance, is a craniotomy for microvascular decompression considered a low, moderate, or high‑risk procedure?
What documentation and coding statement should be used for a high‑complexity new‑patient encounter for a patient referred for new‑onset palpitations with a past medical history of type 2 diabetes mellitus and no prior surgeries?
Should the patient be kept NPO (nothing by mouth) before a CT scan of the abdomen and pelvis?
What alternative medication can be used for a 7‑year‑old with autism spectrum disorder and attention‑deficit/hyperactivity disorder who is experiencing sedation on clonidine 0.1 mg and is about to start school?
In a 17‑year‑old girl with severe posterior neck pain radiating to the shoulders, a cervical X‑ray shows mild loss of cervical lordosis due to muscle spasm, and labs are negative antinuclear antibody and rheumatoid factor <10 IU/mL, what is the most likely diagnosis or impression?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.